Bristol-Myers Squibb buy SVB Leerink LLC
Start price
12.11.24
/
50%
€56.01
Target price
12.11.25
€68.70
Performance (%)
-23.83%
End price
13.11.25
€42.67
Summary
This prediction ended on 13.11.25 with a price of €42.67. The prediction for Bristol-Myers Squibb disappointed with a performance of -23.83%. SVB_Leerink_LLC has a follow-up prediction for Bristol-Myers Squibb where he still thinks Bristol-Myers Squibb is a Buy. A total of €0.60 was paid as dividends for this prediction. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bristol-Myers Squibb | -5.231% | -5.231% | -1.612% |
| iShares Core DAX® | 0,23 % | -2,41 % | 15,34 % |
| iShares Nasdaq 100 | 1,66 % | -1,66 % | 31,09 % |
| iShares Nikkei 225® | -0,21 % | -2,50 % | 43,63 % |
| iShares S&P 500 | 1,07 % | -1,58 % | 24,35 % |
Comments by SVB_Leerink_LLC for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $73.00 price target on the stock, up previously from $55.00.
Ratings data for BMY provided by MarketBeat
In the thread Trading Bristol-Myers Squibb
Die von SVB_Leerink_LLC gewählte maximale Laufzeit wurde überschritten